<DOC>
	<DOCNO>NCT01773226</DOCNO>
	<brief_summary>This prospective single-center study evaluate safety tolerability single dose `` APS ( TM ) '' treat patient OA knee fail conservative OA therapy . The study also evaluate efficacy assess patient pain functionality .</brief_summary>
	<brief_title>Evaluation Intra-articular Injection Autologous Protein Solution ( `` APS ( TM ) '' ) Treatment Osteoarthritis ( OA )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Eligibility Criteria : Male female ≥40 year . Willingness ability comply study procedure visit schedule ability follow verbal write instruction . A stand radiograph knee show Kellgren grade 2 3 Frequency knee pain day last month . Diagnosis unilateral knee OA Body mass index ( BMI ) ≤40 kg/m2 . Failed conservative OA therapy . Signed independent ethic committee ( IEC ) approve informed consent form ( ICF ) . Willingness abstain use topical pain therapy , intraarticular corticosteroid , viscosupplementation study . Willingness abstain systemic pain medication except rescue medication .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Autologous Protein Solution</keyword>
	<keyword>APS</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Injection</keyword>
</DOC>